Legal & General Group
ORGS

Legal & General Group’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Legal & General Group’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-175
Closed -$10K – 3679
2021
Q1 		$10K Hold
175
– – ﹤0.01% 3390
2020
Q4 		$8K Hold
175
– – ﹤0.01% 3400
2020
Q3 		$9K Sell
175
-69
-28% -$3.74K ﹤0.01% 3279
2020
Q2 		$15K Buy
+244
New +$14.8K ﹤0.01% 3196

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Legal & General Group's ORGS Position: Q2 2021 in Review

Legal & General Group sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2021, closing a stake of 175 shares — an estimated $10K sold.

Legal & General Group first reported a position in ORGS in Q2 2020 and held it in 4 quarters. The position peaked at $15K in Q2 2020. 33 funds tracked by Wall St. Rank hold ORGS as of Q2 2021.

  • Legal & General Group reported no remaining Orgenesis Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 175 Orgenesis Inc. Common Stock shares in Q2 2021, an estimated $10K.
  • Legal & General Group first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Legal & General Group's Orgenesis Inc. Common Stock position peaked at $15K in Q2 2020.
  • 33 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.